Literature DB >> 26164465

Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension.

Marcel Ruzicka1, Swapnil Hiremath.   

Abstract

Patients with uncontrolled hypertension on adequate combination and doses of blood pressure-lowering drugs present a diagnostic and therapeutic dilemma. Currently, hypertension guidelines point out uncommon causes of hypertension (either organic such as secondary hypertension or drugs/substances interfering with blood pressure-lowering drugs or causing hypertension) as a cause of hypertension resistance. Non-adherence to drugs, however, is equally, if not more, a cause of hypertension resistance. True resistance to pharmacotherapy is relatively uncommon, as in the majority of patients with non-adherence and/or secondary hypertension, the diagnosis of the problem may potentially lead to better control. Conventionally applied indirect methods to detect non-adherence are inadequate to uncover all cases of non-adherence, especially intentional non-adherence. Rigorous methods to detect non-adherence including direct observed therapy and measuring drug/metabolite levels in body fluids should be considered simultaneously if not before costly and invasive investigations for patients with difficult to control hypertension. However, data on the effectiveness of whether diagnosing non-adherence ultimately controls hypertension is still awaited.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26164465     DOI: 10.1007/s11906-015-0579-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  44 in total

Review 1.  Directly observed therapy for tuberculosis: history of an idea.

Authors:  R Bayer; D Wilkinson
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

2.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

Review 3.  The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Kaberi Dasgupta; Robert R Quinn; Kelly B Zarnke; Doreen M Rabi; Pietro Ravani; Stella S Daskalopoulou; Simon W Rabkin; Luc Trudeau; Ross D Feldman; Lyne Cloutier; Ally Prebtani; Robert J Herman; Simon L Bacon; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Mark Gelfer; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Kevin D Burns; Robert J Petrella; Swapnil Hiremath; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Milan Khara; Andrew Pipe; Paul Oh; Peter Selby; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Raj S Padwal; Luc Poirier
Journal:  Can J Cardiol       Date:  2014-02-22       Impact factor: 5.223

4.  Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.

Authors:  Jiri Ceral; Vilma Habrdova; Viktor Vorisek; Marcel Bima; Radek Pelouch; Miroslav Solar
Journal:  Hypertens Res       Date:  2010-09-30       Impact factor: 3.872

5.  Monitoring adherence to medication by measuring change in blood pressure.

Authors:  Andrew Hayen; Katy Bell; Paul Glasziou; Bruce Neal; Les Irwig
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

6.  Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.

Authors:  Richard J Owen; Swapnil Hiremath; Andy Myers; Margaret Fraser-Hill; Brendan J Barrett
Journal:  Can Assoc Radiol J       Date:  2014-02-20       Impact factor: 2.248

7.  Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia.

Authors:  Tracey-Lea Laba; Jo-Anne Brien; Stephen Jan
Journal:  BMC Fam Pract       Date:  2012-06-20       Impact factor: 2.497

8.  Benefits from treatment and control of patients with resistant hypertension.

Authors:  Michael Doumas; Vasilios Papademetriou; Stella Douma; Charles Faselis; Konstantinos Tsioufis; Eugene Gkaliagkousi; Konstantinos Petidis; Chrysanthos Zamboulis
Journal:  Int J Hypertens       Date:  2010-12-22       Impact factor: 2.420

9.  Unintentional non-adherence to chronic prescription medications: how unintentional is it really?

Authors:  Abhijit S Gadkari; Colleen A McHorney
Journal:  BMC Health Serv Res       Date:  2012-06-14       Impact factor: 2.655

10.  Cost effectiveness of an adherence-improving programme in hypertensive patients.

Authors:  Danielle E M Brunenberg; Gwenn E C Wetzels; Patricia J Nelemans; Carmen D Dirksen; Johan L Severens; Henri E J H Stoffers; Jan S A G Schouten; Martin H Prins; Peter W de Leeuw; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.558

View more
  7 in total

1.  Clinicians' Values and Preferences for Medication Adherence and Cost Clinical Decision Support in Primary Care: A Qualitative Study.

Authors:  Shubha Bhat; Catherine Grace Derington; Katy E Trinkley
Journal:  Appl Clin Inform       Date:  2020-06-03       Impact factor: 2.342

2.  Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Authors:  Valeria Avataneo; Amedeo De Nicolò; Franco Rabbia; Elisa Perlo; Jacopo Burrello; Elena Berra; Marco Pappaccogli; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Franco Veglio
Journal:  Br J Clin Pharmacol       Date:  2018-08-15       Impact factor: 4.335

Review 3.  Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

4.  Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?

Authors:  Larry A Weinrauch; George Bayliss; Alissa R Segal; Jiankang Liu; Eric Wisniewski; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-11       Impact factor: 3.738

5.  Evidence of Nonadherence in Cases of Pseudoresistant Hypertension.

Authors:  João Marcos de Menezes Zanatta; Luciana Neves Cosenso-Martin; Valquíria da Silva Lopes; Jéssica Rodrigues Roma Uyemura; Aleandra Marton Polegati Santos; Manoel Ildefonso Paz Landim; Juan Carlos Yugar-Toledo; José Fernando Vilela-Martin
Journal:  Integr Blood Press Control       Date:  2021-02-11

Review 6.  Rethinking Resistant Hypertension.

Authors:  Gabrielle Bourque; Swapnil Hiremath
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

7.  The Prevalence of Nonadherence in Patients With Resistant Hypertension: A Systematic Review Protocol.

Authors:  Gabrielle Bourque; Julius Vladimir Ilin; Marcel Ruzicka; Alexandra Sascha Davis; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2019-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.